fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Withdrawal ups health risks for persons who inject opioids

Written by | 28 Jul 2020

Article written by Bruce Sylvester Symptoms of opioid withdrawal increase the odds that a drug-injecting person will share needles or have a non-fatal overdose..

FDA accepts for review NDA for furoscix to treat congestive heart failure.- scPharmaceuticals

Written by | 28 Jul 2020

scPharmaceuticals Inc. announced that the FDA has accepted for review the company’s New Drug Application (NDA) resubmission for Furoscix. scPharmaceuticals is developing Furoscix a proprietary, subcutaneously delivered furosemide… read more.

Imfinzi recommended for approval by CHMP for extensive-stage small cell lung cancer. AstraZeneca

Written by | 28 Jul 2020

Imfinzi (durvalumab) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) in combination… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.